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Meigs’ syndrome (MS) is defined as a benign ovarian tumor with pleural effusion and ascites, which, resolve after its re-
moval. The pathogenesis of ascites and pleural effusion in MS is unknown. A 64-year-old woman with a history of uterine fi-
broid was admitted owing to dyspnea over 1 month. A chest radiograph showed right hydrothorax. Carbohydrate antigen 125
(CA-125) level was 645 U/mL. Computed tomography of chest, abdominal, and pelvis showed hydrothorax in the right tho-
racic cavity and atelectasis of the right lower lobe, a tumor, 14 cm in diameter, and ascites in the pelvis. Despite chest drain-
age for hydrothorax, the amount of pleural effusion was over 300 ml/days every day. Pleural fluid was a lymphocyte-
predominant exudate. The bacterial mycobacterial cultures of the pleural fluid were negative. Cytological examination of the
pleural fluid showed no malignancy. As the combination of pleural effusion, ascites, and ovarian tumor was suggestive of
MS, the patient was referred to the Department of Gynecology. She underwent total hysterectomy and bilateral salpingo-
oophorectomy. Histopathological examination of the resected tumor confirmed fibrothecoma. Thus, it is important to con-
sider the possibility of MS in female patients with unexplained pleural effusion and an ovarian tumor.
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Introduction
In 1937, Meigs and Cass reported a series of seven pa-
tients with ascites and pleural effusion associated with
benign ovarian fibroma.
１
Subsequently, this condition
was defined as Meigs’ syndorome (MS). MS has the fol-
lowing four characteristics: (i) benign ovarian fibroma or
fibroma-like tumor; (ii) ascites; (iii) pleural effusion; and
(iv) rapid resolution of ascites and pleural effusion after
removal of the tumor.
２
Case Presentation
A 64-year-old woman with a history of uterine fibroid
was admitted owing to dyspnea over 1 month. She had a
past history of uterine fibroid, hypertension, hyperlipide-
mia, and gastro-esophageal reflux disease.
On admission, her vital signs showed no abnormali-
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Figure　1　Imaging findings.
(A) Chest radiograph showing right hydrothorax.
(B) Chest computed tomogram (CT) of the patient showing hydrothorax in the right thoracic cavity and 
atelectasis of the right lower lobe.
(C) Abdominal CT of the patient showing a tumor, approximately 14 cm in diameter, in the pelvis (red 
arrow).
(D) Abdominal gadolinium-enhanced magnetic resonance imaging of the patient showing a poor 
enhancement tumor, approximately 14 cm in diameter, connected with the ovarian membrane (red ar-
row).
(E) Fluorodeoxyglucose-positron emission tomogram (FDG-PET) of the patient showing an abnormal 
uptake of FDG with a maximum standardized uptake value of 3.53 in the tumor (red arrow).
ties; the respiratory rate was 18 breaths per minutes, and
oxygen saturation was 98% in room air. Laboratory data
revealed a serum total protein (TP) level of 6.7 g/dL, se-
rum lactate dehydrogenase (LDH) levels of 191 U/L, and
serum carbohydrate antigen 125 (CA-125) level of 645
U/mL (normal, below 37 U/mL). Chest radiograph was
suggestive of right hydrothorax (Figure 1A). Computed
tomography (CT) of chest showed hydrothorax in the
right thoracic cavity and atelectasis of the right lower
lobe (Figure 1B). Abdominal CT showed a tumor, ap-
proximately 14 cm in diameter, and ascites in the pelvis
(Figure 1C). An abdominal gadolinium-enhanced mag-
netic resonance imaging (MRI) showed a poor enhance-
ment tumor of approximately 14 cm diameter connected
with ovarian membrane (Figure 1 D ) . Fluorodeoxyg-
lucose-positron emission tomography ( FDG-PET )
showed abdominal uptake of FDG with a maximum stan-
dardized uptake value of 3.53 in the tumor (Figure 1E).
Despite chest drainage for the hydrothorax, the amount
of pleural effusion was over 300 ml/day every day. The
drained pleural fluid was found to be a lymphocyte-
predominant, serous exudate with TP level of 5.0 g/dL
and LDH level of 140 U/L in the pleural fluid, which ful-
filled the Light’s criteria for exudate. The adenosine
deaminase (ADA) and CA-125 levels in pleural fluid
were 5.7 IU/L and 213 U/mL (normal, below 37 U/mL),
respectively. The pleural fluid white blood cell count was
575 / μL, with approximately 90% , lymphocytes. The
pleural fluid cultures were negative for mycobacteria.
The cytological examination of the pleural fluid showed
no malignancy.
As the combined presence of pleural effusion, ascites,
and ovarian tumor was suggestive of MS, the patient was
referred to the Department of Gynecology and underwent
total hysterectomy and bilateral salpingo-oophorectomy.
A cytological examination of the serous ascites showed
no malignancy. Histopathological examination confirmed
the resected tumor as fibrothecoma (Figure 2A). Immu-
nohistochemical analysis revealed that the tumor was
positive for vascular endothelial growth factor (VEGF)
(Figure 2B).
The chest and abdominal drains were removed on the
third postoperative day owing to a decrease in the
amount of pleural effusion and ascites. The patient was
discharged on the seventh postoperative day, and no re-
currence of the hydrothorax was observed for 8 months
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Figure　2　Histological and immunohistochemical findings of the resected tumor.
(A) In hematoxylin and eosin staining, microscopic examination indicated spindle cells were arranged 
in a palisaded pattern and spindle shaped nuclei were without atypia change. The resected tumor con-
firms as a fibrothecoma.
(B) Immunohistochemical analysis revealed that the tumor was positive for vascular endothelial growth 
factor.
Figure　3　Postoperative chest radiograph of the patient showing 
absence of right hydrothorax.
(Figure 3).
Discussion
MS accounts for approximately 1% of ovarian tumors,
ovarian fibromas are found in 2-5% of surgically re-
moved ovarian tumors. Approximately 10-15% of
women with an ovarian fibroma have ascites, and 1%
have hydrothorax. Approximately 70% of the pleural ef-
fusions are right-sided, while 15% are left-sided, and
15% are bilateral.
３
The pathogenesis of ascites and pleu-
ral effusion in MS is unknown. Ascites may result from
edematous fibromas that leak fluid or the increased lym-
phangial pressure in the abdomen and pelvis caused by
the tumor itself. It has been suggested that pleural effu-
sion arises when ascites moves from the peritoneal cavity
to the pleural cavity through diaphragmatic defects or
diaphragmatic lymphatics.
２
Because the lymphatics are
abundant on the right side of the diaphragm, pleural effu-
sion is often seen on the right side. Terada et al.
４
reported
ascites transfer into the thoracic cavity by using
99 m
Tc-
macro-aggregated albumin radioscintigraphy. In this
case, the amount of pleural effusion was more than that
of the ascites. It is considered that diaphragmatic defects
and diaphragmatic lymphatics had developed. Another
theory is that the proteins, such as VEGF that increase
the capillary permeability and some inflammatory cytoki-
nes, including interleukin (IL)-1β, IL-6, and IL-8 are
possible etiologies of ascites and pleural effusion.
５
In a
previous report, VEGF was associated with the produc-
tion of peritoneal and pleural effusion in patients with
malignant and nonmalignant diseases.
６
The increase in
VEGF levels in serum, peritoneal, and pleural effusion in
MS may be attributed to VEGF production by the tumor.
７
Expression of VEGF by tumor cells was also reported in
patients with pseudo-MS.
８
We suggest that VEGF ex-
pression by the ovarian tumor cells may have triggered
development of peritoneal and pleural effusion in our pa-
tient.
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Pleural fluid analysis is important for diagnosis, and it
is classified as either an exudate or a transudate accord-
ing to the Light’s criteria using serum and pleural fluid
TP and LDH.
９
According to a systematic review of 653
studies on MS, a majority of the pleural effusions in pa-
tients were exudates.
１０
In this case, as the pleural fluid
was a lymphocyte-predominant exudate, differentiation
from tuberculosis pleurisy was necessary. Diagnosis of
tuberculosis pleurisy cannot be ruled out only by nega-
tive mycobacterial culture, and it is necessary to evaluate
the pleural biopsy, pleural culture, and pleural fluid ADA
level.
１１
In this case, pleural effusion was unlikely to be
caused by tuberculosis pleurisy because of the negative
mycobacterial culture and normal ADA level findings.
The increase in the tumor maker, CA-125, levels to
80% is confounding factor in ovarian malignancy as well
as in other benign tumors and malignancies.
１２
CA-125 an-
tigen is expressed in the amnion and embryonic coelomic
epithelium. The antigen can also appear in many adult
tissues, including the epithelium of fallopian tubes, en-
dometrium, endocervix, ovaries, peritoneum, and
pleura.
１３
Some normal body tissues can produce a low
level of CA-125 in the serum. CA-125 level is elevated
in menstruation or pregnancy and some benign condi-
tions, such as endometriosis, peritonitis, cirrhosis, or as-
cites. There are some case reports of MS with elevation
of CA-125 level.
１４
In our case, elevation of CA-125 level
in the patient with MS was attributed to ascites.
Treatment of MS comprises removal of the tumor, and
pleural effusion and ascites decrease rapidly after the re-
moval. In this case, pleural effusion decreased signifi-
cantly after the removal, and the disappearance of pleural
effusion was recognized on the third postoperative day.
Conclusion
This was a case of MS with pleural effusion. It is impor-
tant to consider the possibility of MS in female patients
with unexplained pleural effusion and an ovarian tumor.
Although a malignancy must be suspected in all patients
with unexplained pleural effusion, MS can be success-
fully treated by tumor removal.
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